While esophageal cells have been shown to upregulate CXCL10 after IL-17 stimulation [34], whether IL-17A and IL-17F directly upregulate CXCL10 during NAFLD progression remains unexamined. The gene discussed is IL17F; the disease is metabolic dysfunction-associated steatotic liver disease.